Cargando…
The content validity of the PSS in patients with plaque psoriasis
BACKGROUND: The primary objective of this study was to evaluate the content validity of the Psoriasis Symptom Scale (PSS), with a specific focus on understanding of the content of the PRO measure by conducting one-on-one interviews with patients with moderate to severe plaque psoriasis. This was a c...
Autores principales: | Rentz, A. M., Skalicky, A. M., Burslem, K., Becker, K., Kaschinski, D., Esser, D., Revicki, D. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934906/ https://www.ncbi.nlm.nih.gov/pubmed/29757301 http://dx.doi.org/10.1186/s41687-017-0004-7 |
Ejemplares similares
-
Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)
por: Burden, A. David, et al.
Publicado: (2022) -
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
por: Gottlieb, Alice B., et al.
Publicado: (2020) -
The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study
por: Shikiar, Richard, et al.
Publicado: (2006) -
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study
por: Revicki, Dennis A, et al.
Publicado: (2008) -
Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
por: Galluzzo, M, et al.
Publicado: (2019)